Arvinas, Inc. (ARVN) stock
ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$6.76−0.06 (-0.81%)
Close on Nov 18, 2026Market cap $442.34MP/E 42.3Yield –
Arvinas price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Arvinas's price to book ratio was 0.8× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 0.8× to 5.3×, with a median of 2.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.8× | −0.7 |
| 2025 | Dec 31, 2025 | 1.5× | −0.8 |
| 2024 | Dec 31, 2024 | 2.2× | −2.7 |
| 2023 | Dec 29, 2023 | 5.0× | +2.0 |
| 2022 | Dec 30, 2022 | 2.9× | −2.4 |
| 2021 | Dec 31, 2021 | 5.3× | −11.3 |
| 2020 | Dec 31, 2020 | 16.6× | +6.5 |
| 2019 | Dec 31, 2019 | 10.1× | – |
See a number that looks wrong?